|
|
||||||||
| ||||||||||||||||
-positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifenGenes differentially expressed P<0.001) between ERalpha-positive breast tumors with and without relapse.
Files in this Data Supplement:
| ||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |